Digital therapeutics for personalized independent self-management of diabetes
Quin is pioneering a new era of direct-to-consumer Virtual Care 2.0 for diabetes that doesn’t rely on human healthcare professionals. Unlike existing diabetes platforms, which add a digital veneer to already ineffective analogue healthcare models, Quin goes deep into the 24×7 needs of the individual living with the condition. Their groundbreaking personalization model empowers people to better manage on their own, when they’re away from their doctors and living their day-to-day life — where 99.9% of diabetes care actually happens. The first Quin app is a novel digital therapeutic for personalized independent self-management of type 1 diabetes. It regularly ranks in the top #1-3 most-downloaded diabetes apps in the App Store in the UK and Ireland. 96% of Quin users experience better health outcomes or wellbeing, or both. Early data shows a massive opportunity to improve time-in-range (a critical healthcare metric) by 10-20% for those starting at less than 70%.
Learn more about this company on Crunchbase.